Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


4 Am J Respir Crit Care Med
1 Ann Am Thorac Soc
1 Arch Cardiol Mex
1 bioRxiv
2 BMC Pulm Med
1 Can J Anaesth
1 Cardiovasc Diagn Ther
2 Chest
1 Circ Res
1 Clin Respir J
1 Clin Transl Sci
1 Commun Biol
1 Comput Biol Med
1 Curr Heart Fail Rep
1 Egypt Heart J
1 Exp Cell Res
1 Gene
1 Int Immunopharmacol
1 Int J Cardiol
1 Int J Mol Sci
2 J Am Coll Cardiol
1 J Vet Intern Med
2 JACC Cardiovasc Imaging
1 Kardiochir Torakochirurgia Pol
3 Lancet Respir Med
1 Life Sci
1 Parasit Vectors
1 Pulm Circ
1 Res Sq
2 Respir Res
1 Semin Respir Crit Care Med
2 Sheng Li Xue Bao
2 Vascul Pharmacol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Crit Care Med

  1. HAN MK
    From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
    Am J Respir Crit Care Med. 2023;208:339-340.

  2. ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
    Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2023;208:e7-e26.
    PubMed         Abstract available

  3. BRITTAIN EL, Tedford RJ, Maron BA
    Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.

  4. WU Y, Su X, Wang J, Zhang H, et al
    Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.

    Ann Am Thorac Soc

  5. SAHAY S, Lane J, Sharpe MG, Toth D, et al
    Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.
    Ann Am Thorac Soc. 2023 Aug 10. doi: 10.1513/AnnalsATS.202303.
    PubMed         Abstract available

    Arch Cardiol Mex

  6. ROMERO-ZERTUCHE D, Santos-Martinez LE, Loaiza-Sanchez JF, Moreno-Ruiz LA, et al
    Echocardiographic analysis of pulmonary arterial systolic pressure in pulmonary hypertension.
    Arch Cardiol Mex. 2023;93:267-275.
    PubMed         Abstract available


  7. FERNANDEZ-GONZALEZ A, Mukhia A, Nadkarni J, Willis GR, et al
    Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic-pulmonary hypertension.
    bioRxiv. 2023 Aug 2:2023.07.31.551394. doi: 10.1101/2023.07.31.551394.
    PubMed         Abstract available

    BMC Pulm Med

  8. JIN Y, Guo G, Wang C, Jiang B, et al
    Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
    BMC Pulm Med. 2023;23:299.
    PubMed         Abstract available

  9. LIAN G, You J, Lin W, Gao G, et al
    Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
    BMC Pulm Med. 2023;23:300.
    PubMed         Abstract available

    Can J Anaesth

  10. MARCUS B, Marynen F, Fieuws S, Van Beersel D, et al
    The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis.
    Can J Anaesth. 2023 Jun 28. doi: 10.1007/s12630-023-02520.
    PubMed         Abstract available

    Cardiovasc Diagn Ther

  11. YUAN C, Zhang Q
    Risk factors for microalbuminuria in adult Tibetan patients with high-altitude pulmonary hypertension: a cross-sectional study.
    Cardiovasc Diagn Ther. 2023;13:336-344.
    PubMed         Abstract available


  12. MOINZADEH P, Bonella F, Oberste M, Weliwitage J, et al
    Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis.
    Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.
    PubMed         Abstract available

  13. KULARATNE M, Eyries M, Savale L, Humbert M, et al
    Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.
    Chest. 2023;164:e23-e26.
    PubMed         Abstract available

    Circ Res

  14. ZHOU X, Jiang Y, Wang Y, Fan L, et al
    Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
    Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200.
    PubMed         Abstract available

    Clin Respir J

  15. RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
    A systematic review of psychological interventions in adults with pulmonary hypertension: Is the evidence-base disproportionate to the problem?
    Clin Respir J. 2023 Aug 15. doi: 10.1111/crj.13685.
    PubMed         Abstract available

    Clin Transl Sci

  16. YU X, Wu M, Meng Q, Zhu W, et al
    Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells.
    Clin Transl Sci. 2023;16:1369-1380.
    PubMed         Abstract available

    Commun Biol

  17. JOSE A, Elwing JM, Kawut SM, Pauciulo MW, et al
    Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.
    Commun Biol. 2023;6:826.
    PubMed         Abstract available

    Comput Biol Med

  18. LI Y, Fu Y, Liu Y, Zhao D, et al
    An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension.
    Comput Biol Med. 2023;164:107293.
    PubMed         Abstract available

    Curr Heart Fail Rep

  19. NANDULA PS, Shah SD, Caputo A, Papa S, et al
    Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Curr Heart Fail Rep. 2023;20:263-270.
    PubMed         Abstract available

    Egypt Heart J

  20. PUTRA SD, Prakoso R, Sembiring AA, Sakti DDA, et al
    Palliative interatrial septum stenting with a vascular stent in a chronic thromboembolic pulmonary hypertension patient: Is it beneficial?
    Egypt Heart J. 2023;75:70.
    PubMed         Abstract available

    Exp Cell Res

  21. MAIMAITIAILI N, Zeng Y, Ju P, Zhakeer G, et al
    NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-kappaB p65/HIF-1alpha pathway.
    Exp Cell Res. 2023 Aug 14:113755. doi: 10.1016/j.yexcr.2023.113755.
    PubMed         Abstract available


  22. ZI-YANG Y, Nanshan X, Dongling L, Tao H, et al
    ACE2 gene polymorphisms are associated with elevated pulmonary artery pressure in congenital heart diseases.
    Gene. 2023;882:147642.
    PubMed         Abstract available

    Int Immunopharmacol

  23. YUAN J, Li S, Han Y, Li F, et al
    Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3beta/beta-catenin axis.
    Int Immunopharmacol. 2023;123:110599.
    PubMed         Abstract available

    Int J Cardiol

  24. PALMIERO G, Monda E, Verrillo F, Dongiglio F, et al
    Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis.
    Int J Cardiol. 2023;388:131147.
    PubMed         Abstract available

    Int J Mol Sci

  25. DURMUS N, Chen WC, Park SH, Marsh LM, et al
    Resistin-like Molecule alpha and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure.
    Int J Mol Sci. 2023;24:11918.
    PubMed         Abstract available

    J Am Coll Cardiol

  26. COSTANZO MR, Marwick TH
    Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;82:718-720.

  27. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
    Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
    J Am Coll Cardiol. 2023;82:704-717.
    PubMed         Abstract available

    J Vet Intern Med

  28. YUCHI Y, Suzuki R, Saito T, Yasumura Y, et al
    Echocardiographic characteristics of dogs with pulmonary hypertension secondary to respiratory diseases.
    J Vet Intern Med. 2023 Aug 18. doi: 10.1111/jvim.16836.
    PubMed         Abstract available

    JACC Cardiovasc Imaging

  29. ZHONG L, Leng S, Alabed S, Chai P, et al
    Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2023;16:1022-1034.
    PubMed         Abstract available

  30. SANZ J, Nelson KF
    Towards Noninvasive Evaluation of the Right Heart-Pulmonary Circulation Unit.
    JACC Cardiovasc Imaging. 2023;16:1035-1037.

    Kardiochir Torakochirurgia Pol

  31. AMPATZIDOU F, Drosos O, Madesis A, Drossos G, et al
    Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH).
    Kardiochir Torakochirurgia Pol. 2023;20:129-131.

    Lancet Respir Med

  32. OLSSON KM, Corte TJ, Kamp JC, Montani D, et al
    Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00259.
    PubMed         Abstract available

  33. DELCROIX M, de Perrot M, Jais X, Jenkins DP, et al
    Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00292.
    PubMed         Abstract available

  34. NEWMAN J, Pepke-Zaba J
    Illuminating the many faces of pulmonary hypertension.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00291.

    Life Sci

  35. PAHAL P, Sharma S, Braga CL, Santos RT, et al
    Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Life Sci. 2023;329:121988.
    PubMed         Abstract available

    Parasit Vectors

  36. COSTA-RODRIGUEZ N, Garcia-Rodriguez SN, Matos JI, Falcon-Cordon Y, et al
    Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
    Parasit Vectors. 2023;16:292.
    PubMed         Abstract available

    Pulm Circ

  37. JACOBS S, Payne C, Shaboodien S, Kgatla T, et al
    Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too.
    Pulm Circ. 2023;13:e12277.
    PubMed         Abstract available

    Res Sq

  38. KACHABI A, Colebank MJ, Chesler N
    Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
    Res Sq. 2023 Aug 3:rs.3.rs-3214385. doi: 10.21203/rs.3.rs-3214385.
    PubMed         Abstract available

    Respir Res

  39. KATZ MG, Hadas Y, Vincek A, Freage-Kahn L, et al
    Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction.
    Respir Res. 2023;24:197.
    PubMed         Abstract available

  40. KUANG M, Chen Y, Xing Y, Du M, et al
    Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model.
    Respir Res. 2023;24:202.
    PubMed         Abstract available

    Semin Respir Crit Care Med

  41. DELCROIX M, Belge C, Maleux G, Godinas L, et al
    Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Aug 11. doi: 10.1055/s-0043-1770122.
    PubMed         Abstract available

    Sheng Li Xue Bao

  42. LIU XX, Chen AD, Pan Y, Zhang F, et al
    [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
    Sheng Li Xue Bao. 2023;75:497-502.
    PubMed         Abstract available

  43. ZHANG S, Tian YN, Song ZY, Wang XT, et al
    [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
    Sheng Li Xue Bao. 2023;75:503-511.
    PubMed         Abstract available

    Vascul Pharmacol

  44. CULLEY MK, Rao RJ, Mehta M, Zhao J, et al
    Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function.
    Vascul Pharmacol. 2023;151:107181.
    PubMed         Abstract available

  45. ABU-HANNA J, Anastasakis E, Patel JA, Eddama MMR, et al
    Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension.
    Vascul Pharmacol. 2023;151:107194.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.